EGR3 as a potential susceptibility gene for schizophrenia in Korea

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 7, 2010, Pages 1355-1360

  Kim, Se Hyun ^a   Song, Joo Yun ^a,b   Joo, Eun Jeong ^c   Lee, Kyu Young ^c   Ahn, Yong Min ^a,b   Kim, Yong Sik ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Eulji General Hospital   (South Korea)

Author keywords

Early growth response gene; Genetic association; Immediate early gene; Schizophrenia

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 2; EARLY GROWTH RESPONSE FACTOR 3;

ADULT; ARTICLE; AUTOPSY; BRAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; INTRON; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; DOWN-REGULATION; EARLY GROWTH RESPONSE PROTEIN 2; EARLY GROWTH RESPONSE PROTEIN 3; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; KOREA; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 77957369901     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31115     Document Type: Article

References (49)

1. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
2. Beckmann AM, Wilce PA. 1997. Egr transcription factors in the nervous system. Neurochem Int 31:477-510.
3. Berrettini W. 2003. Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet Part C 123C:59-64. (Pubitemid 37356433)
4. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, et al. 1998. Schizophrenia susceptibility locion chromosomes 13q32 and 8p21. Nat Genet 20:70-73.
5. Chiu YF, McGrath JA, Thornquist MH, Wolyniec PS, Nestadt G, Swartz KL, Lasseter VK, Liang KY, Pulver AE. 2002. Genetic heterogeneity in schizophrenia II: Conditional analyses of affected schizophrenia sibling pairs provide evidence for an interaction between markers on chromosome 8p and 14q. Mol Psychiatry 7:658-664.
6. Cordell HJ, Clayton DG. 2002. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: Application to HLA in type 1 diabetes. Am J Hum Genet 70:124-141.
7. Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66:87-98.
8. Gallitano-Mendel A, Izumi Y, Tokuda K, Zorumski CF, Howell MP, Muglia LJ, Wozniak DF, Milbrandt J. 2007. The immediate early gene early growth response gene 3 mediates adaptation to stress and novelty. Neuroscience 148:633-643.
9. Gallitano-Mendel A, Wozniak DF, Pehek EA, Milbrandt J. 2008. Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects. Neuropsychopharmacology 33:1266-1275.
10. Gerber DJ, Hall D, Miyakawa T, Demars S, Gogos JA, Karayiorgou M, Tonegawa S. 2003. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci USA 100:8993-8998.
11. Gogos JA, Gerber DJ. 2006. Schizophrenia susceptibility genes: Emergence of positional candidates and future directions. Trends Pharmacol Sci 27:226-233.
12. Herdegen T, Leah JD. 1998. Inducible and constitutive transcription factors in the mammalian nervous system: Control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev 28:370-490.
13. Hildeman DA, Mitchell T, Kappler J, Marrack P. 2003. T cell apoptosis and reactive oxygen species. J Clin Invest 111:575-581. (Pubitemid 36278573)
14. Jacobson C, Duggan D, Fischbach G. 2004. Neuregulin induces the expression of transcription factors and myosin heavy chains typical of muscle spindles in cultured human muscle. Proc Natl Acad Sci USA 101:12218-12223.
15. Joo EJ, Joo YH, Hong JP, Hwang S, Maeng SJ, Han JH, Yang BH, Lee YS, Kim YS. 2004. Korean version of the diagnostic interview for genetic studies: Validity and reliability. Compr Psychiatry 45:225-229.
16. Jung HY, Kang UG, Ahn YM, Joo YH, Park JB, Kim YS. 1996. Induction of tetradecanoyl phorbol acetate-inducible sequence (TIS) genes by electroconvulsive shock in rat brain. Biol Psychiatry 40:503-507.
17. Kathiresan S, Newton-Cheh C, Gerszten RE. 2004. On the interpretation of genetic association studies. Eur Heart J 25:1378-1381.
18. Kendler KS, MacLean CJ, Ma Y, O'Neill FA, Walsh D, Straub RE. 1999. Marker-to-marker linkage disequilibrium on chromosomes 5q, 6p, and 8p in Irish high-density schizophrenia pedigrees. Am J Med Genet 88:29-33.
19. Kim JJ, Verdu P, Pakstis AJ, Speed WC, Kidd JR, Kidd KK. 2005. Use of autosomal loci for clustering individuals and populations of East Asian origin. Hum Genet 117:511-519.
20. Knapska E, Kaczmarek L. 2004. A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENK? Prog Neurobiol 74:183-211.
21. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. 2003. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177-182.
22. Lohoff FW, Weller AE, Bloch PJ, Buono RJ, Doyle GA, Ferraro TN, Berrettini WH. 2008. Association between polymorphisms in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) on chromosome 8p and schizophrenia. Neuropsychobiology 57:55-60.
23. Mansour HA, Talkowski ME, Wood J, Chowdari KV, McClain L, Prasad K, Montrose D, Fagiolini A, Friedman ES, Allen MH, et al. 2009. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord 11:701-710.
24. Meaney MJ, Diorio J, Francis D, Weaver S, Yau J, Chapman K, Seckl JR. 2000. Postnatal handling increases the expression of cAMP-inducible transcription factors in the rat hippocampus: The effects of thyroid hormones and serotonin. J Neurosci 20:3926-3935.
25. Mexal S, Frank M, Berger R, Adams CE, Ross RG, Freedman R, Leonard S. 2005. Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Brain Res Mol Brain Res 139:317-332.
26. Mittelstadt PR, Ashwell JD. 1998. Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Mol Cell Biol 18:3744-3751.
27. Miyakawa T, Leiter LM, Gerber DJ, Gainetdinov RR, Sotnikova TD, Zeng H, Caron MG, Tonegawa S. 2003. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci USA 100:8987-8992.
28. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T. 1994. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51:849-859, discussion 844-863.
29. O'Donovan KJ, Tourtellotte WG, Millbrandt J, Baraban JM. 1999. The EGR family of transcription-regulatory factors: Progress at the interface of molecular and systems neuroscience. Trends Neurosci 22:167-173.
30. O'Donovan KJ, Levkovitz Y, Ahn D, Baraban JM. 2000. Functional comparison of Egr3 transcription factor isoforms: Identification of an activation domain in the N-terminal segment absent from Egr3beta, a major isoform expressed in brain. J Neurochem 75:1352-1357.
31. Ophoff RA, Escamilla MA, Service SK, Spesny M, Meshi DB, Poon W, Molina J, Fournier E, Gallegos A, Mathews C, et al. 2002. Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate. Am J Hum Genet 71:565-574.
32. Perry GH, Ben-Dor A, Tsalenko A, Sampas N, Rodriguez-Revenga L, Tran CW, Scheffer A, Steinfeld I, Tsang P, Yamada NA, et al. 2008. The finescale and complex architecture of human copy-number variation. Am J Hum Genet 82:685-695.
33. Poirier R, Cheval H, Mailhes C, Charnay P, Davis S, Laroche S. 2007. Paradoxical role of an egr transcription factor family member, egr2/krox20, in learning and memory. Front Behav Neurosci 1:6.
34. Poirier R, Cheval H, Mailhes C, Garel S, Charnay P, Davis S, Laroche S. 2008. Distinct functions of egr gene family members in cognitive processes. Front Neurosci 2:47-55.
35. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, et al. 2006. Global variation in copy number in the human genome. Nature 444:444-454. (Pubitemid 44809057)
36. Riley B, Kendler KS. 2006. Molecular genetic studies of schizophrenia. Eur J Hum Genet 14:669-680.
37. Roberts DS, Raol YH, Bandyopadhyay S, Lund IV, Budreck EC, Passini MA, Wolfe JH, Brooks-Kayal AR, Russek SJ. 2005. Egr3 stimulation of GABRA4 promoter activity as a mechanism for seizure-induced up-regulation of GABA(A) receptor alpha4 subunit expression. Proc Natl Acad Sci USA 102:11894-11899.
38. Roberts DS, Hu Y, Lund IV, Brooks-Kayal AR, Russek SJ. 2006. Brain-derived neurotrophic factor (BDNF)-induced synthesis of early growth response factor 3 (Egr3) controls the levels of type A GABA receptor alpha 4 subunits in hippocampal neurons. J Biol Chem 281:29431-29435.
39. Senba E, Ueyama T. 1997. Stress-induced expression of immediate early genes in the brain and peripheral organs of the rat. Neurosci Res 29:183-207.
40. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, et al. 2002. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71:877-892.
41. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, Gunnarsdottir S, Walker N, Petursson H, Crombie C, et al. 2003. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 72:83-87.
42. Straub RE, Weinberger DR. 2006. Schizophrenia genes - Famine to feast. Biol Psychiatry 60:81-83.
43. Tabares-Seisdedos R, Rubenstein JL. 2009. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: Implications for schizophrenia, autism and cancer. Mol Psychiatry 14:563-589.
44. Tian C, Kosoy R, Lee A, Ransom M, Belmont JW, Gregersen PK, Seldin MF. 2008. Analysis of East Asia genetic substructure using genome-wide SNP arrays. PLoS One 3:e3862.
45. Verma V, Rasmussen K, Dawe GS. 2006. Effects of short-term and chronic olanzapine treatment on immediate early gene protein and tyrosine hydroxylase immunoreactivity in the rat locus coeruleus and medial prefrontal cortex. Neuroscience 143:573-585.
46. Verma V, Lim EP, Han SP, Nagarajah R, Dawe GS. 2007. Chronic high-dose haloperidol has qualitatively similar effects to risperidone and clozapine on immediate-early gene and tyrosine hydroxylase expression in the rat locus coeruleus but not medial prefrontal cortex. Neurosci Res 57:17-28.
47. von der Kammer H, Mayhaus M, Albrecht C, Enderich J, Wegner M, Nitsch RM. 1998. Muscarinic acetylcholine receptors activate expression of the EGR gene family of transcription factors. J Biol Chem 273:14538-14544.
48. Yamada K, Gerber DJ, Iwayama Y, Ohnishi T, Ohba H, Toyota T, Aruga J, Minabe Y, Tonegawa S, Yoshikawa T. 2007. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc Natl Acad Sci USA 104:2815-2820.
49. Yamagata K, Kaufmann WE, Lanahan A, Papapavlou M, Barnes CA, Andreasson KI, Worley PF. 1994. Egr3/Pilot, a zinc finger transcription factor, is rapidly regulated by activity in brain neurons and colocalizes with Egr1/zif268. Learn Mem 1:140-152.